ClinicalTrials.gg
CompletedNCT03463863Updated Mar 16, 2018

Midurethral Sling With Autologus Rectus Sheath

A Phase 3 interventional study of rectus sheath midurethral sling in Stress Urinary Incontinence, sponsored by sarah mohamed hassan. Completed at 1 site in Egypt. Open to female participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-03-16.

Sponsored by sarah mohamed hassan · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Aug 2016, registered Mar 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
25 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 39 studies in Urinary Incontinence, Stress with a site in Egypt — 15 open to participants now, 19 under way, none of them phase 3. Urinary Incontinence, Stress · Egypt.

Enrollment
10th of 31
70 · median 60
Started
2016
with 3 others
Phase 3
3 of 39
none open now
Registered
8th of 39
by date
Lead sponsor
2 of 39
sarah mohamed hassan

Among the 39 studies in Urinary Incontinence, Stress with a site in Egypt, this one is the 10th largest by enrollment of the 31 interventional ones that give a count, is one of 4 that started in 2016, is one of 3 in phase 3, and was the 8th registered.

Urinary Incontinence, Stress

653 studies on the registry are indexed under Urinary Incontinence, Stress; 121 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

15 of the 39 studies in Urinary Incontinence, Stress with a site in Egypt are open now. Recruiting first, the newest first:

10 more — sign in →

All 15 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 74 Urinary Incontinence, Stress studies recruiting now, 42 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 25 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Urinary Incontinence, Stress with a site in Egypt, or all of them as a file.
02

Study summary

assessment of the safety and efficacy surgeon tailored rectus sheath midurethral sling

Read the detailed description

the rectus sheath is harvested in 5 cm length and 2 cm width , A 2cm width 8 cm length polypropolyine mesh is attached to the harvest rectus sheet sling on both side The procedure is carried with a similar technique to the outside in TOT.

03

Conditions studied

  • Stress Urinary Incontinence
04

Who can participate

Ages eligible
25 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • stress incontinence

Exclusion criteria

Exclusion Criteria:

  • overactive bladder
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
70 participants (actual)

Interventions

  • Procedurerectus sheath midurethral sling
06

What researchers measure

Primary outcomes

  1. cure rate of stress incontinence

    history and urodynamic study

    Time frame: one year after surgery

07

Study locations

1 site
  • Kasr El Ainiy Hospital
    Cairo, 11562, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2016 to primary completion in Jan 2018, 17 months.

Of 14 phase 3 interventional studies under Urinary Incontinence, Stress, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 51. This study's 17 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2018
First posted
Mar 13, 2018
StartActual
Aug 10, 2016
Primary completionActual
Jan 2018
CompletionActual
Jan 2018
Last update
Mar 16, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03463863
Lead sponsor
sarah mohamed hassan
Responsible party
sarah mohamed hassan (lecturer of obstetrics and gynecology, Kasr El Aini Hospital) — Sponsor-investigator
First posted
Mar 13, 2018
Start date
Aug 10, 2016
Primary completion
Jan 2018
Completion
Jan 2018
Last update
Mar 16, 2018

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion